A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis

Conditions

Atopic Dermatitis

What is the purpose of this trial?

This is an observational study to assess the long-term safety of Protopic® Ointment for the treatment of atopic dermatitis. Patients whose ages are/were < 16 years at the time of first tacrolimus ointment exposure are eligible to participate. No drug is distributed during this observational trial.



Participation Guidelines

Age:
Up to 16 Years
Gender:
Both

Click here for detailed information about who can participate in this trial.


Sponsor:
Astellas Pharma Inc
Dates:
May 2005
Last Updated:
March 31, 2011
Study HIC#:
0506000135

Clinicaltrials.gov ID: NCT00475605